BESREMI
Live / Allowed — Notice of allowance issued (as of 06 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 09 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99129369
- Mark type
- Design + words
- Filed
- 09 Apr 2025
- Published for opposition
- 11 Nov 2025
- Attorney of record
- chainey Singleton
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in for the treatment of viral infections, cancers, or essential thrombocythemia (ET); Pharmaceutical preparations, namely, antineoplastic and immunomodulating agents; pharmaceutical preparations containing ropeginterferon alfa-2b for the treatment of viral infections, cancers, or essential thrombocythemia (ET); medicines for human purposes for treating viral infections, cancers, or ET; chemical-pharmaceutical preparations containing ropeginterferon alfa-2b for treating viral infections, cancers, or ET
Owner
- PHARMAESSENTIA CORPORATION, Taipei City 115, TW
- PHARMAESSENTIA CORPORATION, Taipei City 115, TW
Prosecution history
- 06 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Nov 2025 — PUBLISHED FOR OPPOSITION
- 05 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Sept 2025 — NON-FINAL ACTION E-MAILED
- 05 Sept 2025 — NON-FINAL ACTION WRITTEN
- 05 Sept 2025 — ASSIGNED TO EXAMINER
- 20 Aug 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 20 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 09 Apr 2025 — APPLICATION FILING RECEIPT MAILED